{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:42:42Z","timestamp":1792086162168,"version":"4.4.0"},"reference-count":51,"publisher":"American Society for Clinical Investigation","issue":"6","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"crossref","award":["R01HL134923-01"],"award-info":[{"award-number":["R01HL134923-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,21]]},"abstract":"<jats:p>About one-third of dilated cardiomyopathy (DCM) cases are caused by mutations in sarcomere or cytoskeletal proteins. However, treating the cytoskeleton directly is not possible because drugs that bind to actin are not well tolerated. Mutations in the actin binding protein CAP2 can cause DCM and KO mice, either whole body (CAP2-KO) or cardiomyocyte-specific KOs (CAP2-CKO) develop DCM with cardiac conduction disease. RNA sequencing analysis of CAP2-KO hearts and isolated cardiomyocytes revealed overactivation of fetal genes, including serum response factor\u2013regulated (SRF-regulated) genes such as Myl9 and Acta2 prior to the emergence of cardiac disease. To test if we could treat CAP2-KO mice, we synthesized and tested the SRF inhibitor CCG-1423-8u. CCG-1423-8u reduced expression of the SRF targets Myl9 and Acta2, as well as the biomarker of heart failure, Nppa. The median survival of CAP2-CKO mice was 98 days, while CCG-1423-8u\u2013treated CKO mice survived for 116 days and also maintained normal cardiac function longer. These results suggest that some forms of sudden cardiac death and cardiac conduction disease are under cytoskeletal stress and that inhibiting signaling through SRF may benefit DCM by reducing cytoskeletal stress.<\/jats:p>","DOI":"10.1172\/jci.insight.124629","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T12:00:39Z","timestamp":1550145639000},"source":"Crossref","is-referenced-by-count":9,"title":["Targeting MRTF\/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset"],"prefix":"10.1172","volume":"4","author":[{"given":"Yao","family":"Xiong","sequence":"first","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Bedi","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Berritt","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Merck High throughput Experimentation Laboratory, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennette K.","family":"Attipoe","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-0079","authenticated-orcid":true,"given":"Thomas G.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8093-4465","authenticated-orcid":true,"given":"Kenneth B.","family":"Margulies","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7161-7284","authenticated-orcid":true,"given":"Jeffrey","family":"Field","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.023838"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5364.750"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309396"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201101100"},{"issue":"12","key":"B5","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","article-title":"Regulation of fetal gene expression in heart failure","volume":"1832","author":"Dirkx","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81011-9"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2006.09.008"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90812-S"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90813-T"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.17.3.1057"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.001779"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3252"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04231-7"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00117-06"},{"issue":"Pt 15","key":"B15","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1242\/jcs.128231","article-title":"The role of cyclase-associated protein in regulating actin filament dynamics - more than a monomer-sequestration factor","volume":"126","author":"Ono","year":"2013","journal-title":"J Cell Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.784"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.140"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ng.511"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3014"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1186\/1755-8166-5-17","article-title":"Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders","volume":"5","author":"Celestino-Soper","year":"2012","journal-title":"Mol Cytogenet"},{"key":"B21"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1142-y"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1038\/srep17256","article-title":"CAP2 in cardiac conduction, sudden cardiac death and eye development","volume":"5","author":"Field","year":"2015","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0782"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.04.080"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.010470"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.010447"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.12.5281-5289.2004"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.533778"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.280.4.H1782"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139858"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012630"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000159390.03503.c3"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303113200"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00156.2016"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.234591"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00102","article-title":"The case for inhibiting p38 mitogen-activated protein kinase in heart failure","volume":"6","author":"Arabacilar","year":"2015","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.213520"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.02.070"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.2.308"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.8.1154"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.04.008"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29042"},{"issue":"7-8","key":"B44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbadis.2010.04.001","article-title":"Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene","volume":"1802","author":"Wu","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr301"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.970673"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.006346"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-015-0256-6","article-title":"Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension","volume":"14","author":"Waddingham","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature12105"},{"issue":"6","key":"B50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86898","article-title":"Molecular profiling of dilated cardiomyopathy that progresses to heart failure","volume":"1","author":"Burke","year":"2016","journal-title":"JCI Insight"},{"issue":"87","key":"B51","doi-asserted-by":"crossref","DOI":"10.3791\/51357-v","article-title":"Isolation and culture of adult mouse cardiomyocytes for cell signaling and in vitro cardiac hypertrophy","volume":"87","author":"Li","year":"2014","journal-title":"J Vis Exp"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/124629\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:32:27Z","timestamp":1779193947000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/124629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3,21]]},"published-print":{"date-parts":[[2019,3,21]]}},"alternative-id":["10.1172\/jci.insight.124629"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.124629","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"article-number":"e124629"}}